Richard Motruk has over 15 years of combined experience in the biopharmaceutical and medical device industries. He earned a Bachelor of Science in Biochemistry and Molecular Biology from Penn State University. He brings his proven expertise leading both technical and operations-focused teams, small and large, to Kymanox and their client base.
In regards to his new employment at Kymanox, Mr. Motruk expressed his excitement in being able to leverage his diverse Life Science experience to assist clients improve their operational efficiencies while maintaining or exceeding their quality and compliance levels. “Kymanox is highly regarded for its expertise in many facets of CGMP manufacturing, chemistry, and related controls. The idea of joining an industry leader, and being able to parlay my operational leadership experience gained at bioMérieux, Teva, and OraSure, is very exciting,” he said.
Richard is a welcome addition to the Kymanox team, CEO and Founder Stephen M. Perry remarked. “With Richard now directing our established Process Operations and Validation groups, this new leadership position lays a solid foundation for future, sustainable growth,” he said. “This helps make the Kymanox team even more capable to address challenges with bringing modern medicines to patients in need across the globe.”